Clinical Trial Update: BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing losartan/hydrochlorothiazide (50/12.5 mg) to valsartan/hydrochlorothiazide (80/12.5 mg) titrated as needed in patients with essential …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Diovan HCT (valsartan/hydrochlorothiazide)
• Hyzaar (losartan/hydrochlorothiazide)

Snippet

Sponsor: Organon and Co | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2010-04-13